Support
Executive Order 14200

Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China

Signed 2025-02-05 in effect
TariffsTradeChina
Trade & TariffsForeign Policy & National SecurityHealth

First of several amendments escalating tariffs on Chinese imports. Blocked in court as part of the IEEPA tariff litigation.

View on GovInfo (PDF) Federal Register

Section by Section

What each section does, and how they differ.

Sec. 1 Amendment

Amends the February 1, 2025 fentanyl tariff order to allow duty-free de minimis treatment only after customs systems are ready.

Sec. 2 General Provisions

Standard boilerplate: preserves existing agency authority, conditions the order on appropriations, and creates no enforceable private rights.

Related Executive Orders

EO 14195 Imposing Duties to Address the Synthetic Opioid Supply Chain in the People's Republic of China EO 14228 Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China EO 14256 Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China as Applied to Low-Value Imports

Same subject matter

EO 14357 Modifying Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China EO 14358 Modifying Reciprocal Tariff Rates Consistent With the Economic and Trade Arrangement Between the United States and the People's Republic of China EO 14298 Modifying Reciprocal Tariff Rates to Reflect Discussions with the People's Republic of China EO 14407 Realigning United States Core Childhood Vaccine Recommendations With Best Practices From Peer, Developed Countries EO 14388 Continuing the Suspension of Duty-Free De Minimis Treatment for All Countries EO 14389 Ending Certain Tariff Actions
February 2025